Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of Cancer: An Overview of Systematic ReviewsShunlong Ou, Qian Jiang, Jing Luo et al.|Frontiers in Immunology|2022Cited by 22
Knowledge mapping of autophagy in osteoarthritis from 2004 to 2022: A bibliometric analysisJiahe Liao, Qingwen Tao, Xinbo Yu et al.|Frontiers in Immunology|2023Cited by 18
Advancing perspectives on the off-label use of anticancer drugs: an updated classification and exploration of categoriesXiaoyi Chen, Qian Jiang, Shunlong Ou et al.|Frontiers in Pharmacology|2024Cited by 6